Nvidia launches BioNeMo Agent Toolkit for AI-driven drug discovery

The June 23 debut at the BIO International Convention packages Nvidia’s life sciences models and tools into autonomous AI workflows, with Certara among early adopters and more than 50 companies expected to join.

RENDER

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.